Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neuron ; 87(1): 124-38, 2015 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-26074006

RESUMEN

Chronic itch is a prevalent and debilitating condition for which few effective therapies are available. We harnessed the natural variation across genetically distinct mouse strains to identify transcripts co-regulated with itch behavior. This survey led to the discovery of the serotonin receptor HTR7 as a key mediator of serotonergic itch. Activation of HTR7 promoted opening of the ion channel TRPA1, which in turn triggered itch behaviors. In addition, acute itch triggered by serotonin or a selective serotonin reuptake inhibitor required both HTR7 and TRPA1. Aberrant serotonin signaling has long been linked to a variety of human chronic itch conditions, including atopic dermatitis. In a mouse model of atopic dermatitis, mice lacking HTR7 or TRPA1 displayed reduced scratching and skin lesion severity. These data highlight a role for HTR7 in acute and chronic itch and suggest that HTR7 antagonists may be useful for treating a variety of pathological itch conditions.


Asunto(s)
Dermatitis Atópica/genética , Ratones Endogámicos C57BL/genética , Ratones Endogámicos DBA/genética , Prurito/genética , ARN Mensajero/metabolismo , Receptores de Serotonina/genética , Canales de Potencial de Receptor Transitorio/genética , Enfermedad Aguda , Animales , Enfermedad Crónica , Dermatitis Atópica/metabolismo , Modelos Animales de Enfermedad , Ganglios Espinales/metabolismo , Perfilación de la Expresión Génica , Humanos , Ratones , Ratones Endogámicos C57BL/metabolismo , Ratones Endogámicos DBA/metabolismo , Prurito/inducido químicamente , Prurito/metabolismo , Receptores de Serotonina/efectos de los fármacos , Receptores de Serotonina/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Serotonina/farmacología , Agonistas de Receptores de Serotonina/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Canal Catiónico TRPA1 , Canales de Potencial de Receptor Transitorio/efectos de los fármacos , Canales de Potencial de Receptor Transitorio/metabolismo
2.
Cell ; 155(2): 285-95, 2013 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-24094650

RESUMEN

Atopic dermatitis (AD) is a chronic itch and inflammatory disorder of the skin that affects one in ten people. Patients suffering from severe AD eventually progress to develop asthma and allergic rhinitis, in a process known as the "atopic march." Signaling between epithelial cells and innate immune cells via the cytokine thymic stromal lymphopoietin (TSLP) is thought to drive AD and the atopic march. Here, we report that epithelial cells directly communicate to cutaneous sensory neurons via TSLP to promote itch. We identify the ORAI1/NFAT calcium signaling pathway as an essential regulator of TSLP release from keratinocytes, the primary epithelial cells of the skin. TSLP then acts directly on a subset of TRPA1-positive sensory neurons to trigger robust itch behaviors. Our results support a model whereby calcium-dependent TSLP release by keratinocytes activates both primary afferent neurons and immune cells to promote inflammatory responses in the skin and airways.


Asunto(s)
Citocinas/metabolismo , Dermatitis Atópica/patología , Transducción de Señal , Animales , Calcio/metabolismo , Células Cultivadas , Dermatitis Atópica/metabolismo , Humanos , Inmunoglobulinas/metabolismo , Queratinocitos/metabolismo , Prurito/inmunología , Receptores de Citocinas/metabolismo , Células Receptoras Sensoriales/metabolismo , Piel/metabolismo , Piel/patología , Canal Catiónico TRPA1 , Canales de Potencial de Receptor Transitorio/metabolismo , Linfopoyetina del Estroma Tímico
3.
Gend Med ; 6(3): 488-97, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19850245

RESUMEN

BACKGROUND: Genistein, a naturally occurring isoflavonic phytoestrogen associated with reduced incidence of heart disease, may be a possible alternative treatment for postmenopausal women with heart disease. OBJECTIVE: This study examined the effects of genistein on in vitro heart function and ischemic tolerance in ovariectomized (OVX) Sprague-Dawley rats. METHODS: To examine the acute effects of genistein on cardiac function, isolated working hearts were perfused under aerobic conditions with increasing concentrations of genistein (10-150 microM). A separate group of OVX rats was used to assess ischemic tolerance: treated rats received genistein (250 mg/kg, dissolved in 200 microL dimethyl sulfoxide [DMSO]) injected once daily for 2 days, and control rats received DMSO only. After treatment, hearts were perfused for 30 minutes under aerobic conditions and then subjected to 20 minutes of global no-flow ischemia by clamping the preload and afterload lines, followed by 30 minutes of reperfusion. RESULTS: Genistein was associated with improvements in mechanical function in OVX rat hearts (n = 5) with maximum increases in contractility (259 mm Hg/sec above baseline) and cardiac output (7 mL/min above baseline) observed with 30 microM of genistein (both, P < 0.05). Relative to baseline, genistein-treated hearts (n = 5) also had greater ischemic tolerance than did control hearts (n = 6) and significant improvements in mean (SEM) recovery of contractility (to 75.0% [9.7%] of preischemic function; P < 0.05) and cardiac output (to 48.8% [12.3%] of preischemic function; P < 0.05) after reperfusion. These effects occurred without significant changes in myocardial levels of nonprotein thiols or thiobarbituric acid reactive substances, although a reduction in mean glucose transporter protein 4 content (13.2% [2.7%]; P < 0.05) was observed in genistein-treated hearts. No significant changes in blood pressure were observed with genistein. CONCLUSIONS: Despite the lack of significant changes in physical characteristics, 2-day treatment with genistein was associated with significant cardioprotective effects in OVX rats, suggesting a potential therapeutic role in postmenopausal women.


Asunto(s)
Genisteína/administración & dosificación , Isquemia/tratamiento farmacológico , Contracción Miocárdica/efectos de los fármacos , Fitoestrógenos/administración & dosificación , Posmenopausia/efectos de los fármacos , Animales , Modelos Animales de Enfermedad , Femenino , Técnicas In Vitro , Ovariectomía , Ratas , Ratas Sprague-Dawley
4.
Alcohol ; 43(2): 147-61, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19251116

RESUMEN

Fetal alcohol syndrome (FAS), a condition occurring in some children of mothers who have consumed alcohol during pregnancy, is characterized by physical deformities and learning and memory deficits. The chick hippocampus, whose functions are controlled by interneurons expressing calcium-binding proteins parvalbumin (PV) and calretinin (CR), is involved in learning and memory mechanisms. Effects on growth and development and hippocampal morphology were studied in chick embryos exposed to 5% and 10% ethanol volume/volume (vol/vol) for 2 or 8 days of gestation. There was a significant dose-dependent reduction (P<.05) in body weight and mean number per section of PV and CR expressing hippocampal neurons in ethanol-exposed chicks, without alterations in neuronal nuclear size or hippocampal volume, compared appropriate controls. Moreover, when chicks exposed to 5% ethanol for 2 and 8 days of gestation were compared, no significant differences were found in body parameters or neuronal counts. Similarly, exposure to 10% ethanol did not induce any significant changes in chicks exposed for 2 or 8 gestational days. Thus, these results suggest that gestational ethanol exposure induces a reduction in the mean number per section of PV and CR expressing hippocampal neurons, and could be a possible mechanism responsible for learning and memory disorders in FAS.


Asunto(s)
Embrión de Pollo/efectos de los fármacos , Etanol/toxicidad , Trastornos del Espectro Alcohólico Fetal/fisiopatología , Hipocampo/efectos de los fármacos , Parvalbúminas/biosíntesis , Proteína G de Unión al Calcio S100/biosíntesis , Animales , Calbindina 2 , Embrión de Pollo/metabolismo , Modelos Animales de Enfermedad , Femenino , Expresión Génica/efectos de los fármacos , Hipocampo/metabolismo , Hipocampo/ultraestructura , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Parvalbúminas/metabolismo , Embarazo
5.
Toxicol In Vitro ; 21(5): 770-81, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17314029

RESUMEN

We studied the effect of the estrogenic pesticide methoxychlor (MXC) on skeletal muscle development using C2C12 cell culture. Myoblast cultures were exposed to various concentrations of MXC at various times during the process of myoblast fusion into myotubes. We observed that MXC exposure decreased myotube formation. In addition, we observed myoblasts with cytoplasmic vacuoles in cultures exposed to MXC. Because cytoplasmic vacuoles can be characteristic of cell death, apoptosis assays and trypan blue exclusion assays were performed. We found no difference in the frequency of apoptosis or in the frequency of cell death for cultures exposed to MXC and untreated cultures. Collectively, these results indicate that MXC exposure decreases myotube formation without causing cell death. In contrast, when cell proliferation was assessed, untreated cultures had a myoblast proliferation rate 50% greater than cultures exposed to MXC. We conclude that MXC decreases myotube formation at least in part by slowing myoblast proliferation. Furthermore, we suggest that direct exposure to MXC could affect skeletal muscle development in animals or humans, in addition to the defects in reproductive development that have previously been reported.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Insecticidas/toxicidad , Metoxicloro/toxicidad , Fibras Musculares Esqueléticas/efectos de los fármacos , Mioblastos/efectos de los fármacos , Agrina/farmacología , Animales , Apoptosis/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Depresión Química , Ratones , Fibras Musculares Esqueléticas/ultraestructura , Mioblastos/ultraestructura , Receptores Colinérgicos/efectos de los fármacos , Receptores Colinérgicos/metabolismo , Azul de Tripano
6.
Am J Obstet Gynecol ; 195(5): 1398-403, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16723106

RESUMEN

OBJECTIVE: We hypothesized that cardiac function would be reduced in a pregnant rat model of preeclampsia induced by L-NAME, a NOS inhibitor, and be reversed with magnesium sulfate prophylaxis. STUDY DESIGN: Female Sprague-Dawley rats were bred in-house. On gestational day 17, rats were anesthetized and osmotic minipumps were implanted to continuously deliver saline, L-NAME, or L-NAME and MgSO4. On gestational day 21, hearts were isolated and perfused in the working mode using Krebs Henseleit buffer. RESULTS: Pregnant rats treated with L-NAME displayed significant hypertension compared to the saline-treated controls (P < 0.05). Moreover, cardiac output and cardiac work were significantly reduced in the L-NAME-treated rats compared to controls (P < 0.05). In the L-NAME-treated rats given MgSO4, cardiac function remained normal. CONCLUSION: Cardiac function is depressed in an animal model of preeclampsia induced by L-NAME infusion. MgSO4 prevented the reduction in cardiac function and is clearly beneficial in preserving normal heart function in preeclampsia.


Asunto(s)
Sulfato de Magnesio/uso terapéutico , Preeclampsia/tratamiento farmacológico , Disfunción Ventricular Izquierda/prevención & control , Animales , Gasto Cardíaco , Modelos Animales de Enfermedad , Inhibidores Enzimáticos , Femenino , Corazón/efectos de los fármacos , Corazón/fisiopatología , Hipertensión/fisiopatología , NG-Nitroarginina Metil Éster , Preeclampsia/inducido químicamente , Preeclampsia/fisiopatología , Embarazo , Ratas , Ratas Sprague-Dawley
7.
J Am Osteopath Assoc ; 106(3): 157-66, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16585384

RESUMEN

CONTEXT: Normal physiologic movement, pathologic conditions, and osteopathic manipulative treatment (OMT) are believed to produce effects on the shape and proliferation of human fibroblasts. Studies of biophysically strained fibroblasts would be useful in producing a model of the cellular mechanisms underlying OMT. OBJECTIVE: To investigate the effects of acyclic in vitro biophysical strain on normal human dermal fibroblasts and observe potential changes in cellular shape and proliferation, as well as potential changes in cellular production of nitric oxide, interleukin (IL) 1beta, and IL-6. DESIGN AND METHODS: Randomized controlled trial. Human fibroblasts were subjected in vitro to control conditions (no strain) or biophysical strain of various magnitudes (10%-30% beyond resting length) and durations (12-72 hours). After control or strain stimuli, fibroblasts were analyzed for potential changes in cell shape, proliferative capacity, nitric oxide secretion, and cytokine (IL-1beta, IL-6) secretion. RESULTS: Low strain magnitudes (<20%) induced mild cellular rounding and pseudopodia truncation. High strain magnitudes (>20%) decreased overall cell viability and the mitogenic response, and induced cell membrane decomposition and pseudopodia loss. No basal or strain-induced secretion of IL-1beta was observed. Interleukin 6 concentrations increased two-fold, while nitric oxide levels increased three-fold, in cells strained at 10% magnitude for 72 hours (P<.05). CONCLUSION: Human fibroblasts respond to in vitro strain by secreting inflammatory cytokines, undergoing hyperplasia, and altering cell shape and alignment. The in vitro biophysical strain model developed by the authors is useful for simulating a variety of injuries, determining in vivo mediators of somatic dysfunction, and investigating the underlying mechanisms of OMT.


Asunto(s)
Citocinas/metabolismo , Fibroblastos/citología , Osteopatía , Fenómenos Biomecánicos , Células Cultivadas , Citocinas/análisis , Humanos , Técnicas In Vitro , Factores de Riesgo , Sensibilidad y Especificidad , Esguinces y Distensiones/fisiopatología , Estrés Mecánico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...